Collegium Pharmaceutical, Inc. (COLL)
48.80
-0.21
(-0.43%)
USD |
NASDAQ |
Dec 16, 15:09
Collegium Pharmaceutical Research and Development Expense (Annual): 0.00 for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 12.65M |
| Alnylam Pharmaceuticals, Inc. | 1.126B |
| Altimmune, Inc. | 81.99M |
| Vertex Pharmaceuticals, Inc. | 3.630B |
| Viking Therapeutics, Inc. | 101.64M |